Price
$107.34
Decreased by -4.72%
Dollar volume (20D)
214.72 M
ADR%
2.55
Earnings report date
Apr 30, 2025
Shares float
198.48 M
Shares short
6.22 M [3.14%]
Shares outstanding
199.06 M
Market cap
22.43 B
Beta
0.84
Price/earnings
25.43
20D range
103.21 114.44
50D range
97.48 114.44
200D range
97.48 115.94

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide.

The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products;S. E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

It offers technology and data, bone cement, and surgical products.

The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues.

It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups.

The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015.

Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Feb 6, 25 2.31
Increased by +5.00%
2.29
Increased by +0.75%
Oct 30, 24 1.74
Increased by +5.45%
1.74
Aug 7, 24 2.01
Increased by +10.44%
1.99
Increased by +1.01%
May 2, 24 1.94
Increased by +2.65%
1.87
Increased by +3.74%
Feb 8, 24 2.20
Increased by +17.02%
2.15
Increased by +2.33%
Nov 7, 23 1.65
Increased by +4.43%
1.60
Increased by +3.12%
Aug 1, 23 1.82
Increased by 0.00%
1.81
Increased by +0.55%
May 2, 23 1.89
Increased by +17.39%
1.64
Increased by +15.24%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Dec 31, 24 2.02 B
Increased by +4.28%
239.50 M
Decreased by -42.87%
Increased by +11.84%
Decreased by -45.21%
Sep 30, 24 1.82 B
Increased by +4.03%
249.20 M
Increased by +53.17%
Increased by +13.66%
Increased by +47.24%
Jun 30, 24 1.94 B
Increased by +3.87%
242.80 M
Increased by +15.84%
Increased by +12.50%
Increased by +11.52%
Mar 31, 24 1.89 B
Increased by +3.18%
172.40 M
Decreased by -25.85%
Increased by +9.13%
Decreased by -28.13%
Dec 31, 23 1.94 B
Increased by +6.30%
419.20 M
Increased by +421.97%
Increased by +21.61%
Increased by +402.88%
Sep 30, 23 1.75 B
Increased by +5.02%
162.70 M
Decreased by -16.13%
Increased by +9.28%
Decreased by -20.14%
Jun 30, 23 1.87 B
Increased by +4.93%
209.60 M
Increased by +36.37%
Increased by +11.21%
Increased by +29.97%
Mar 31, 23 1.83 B
Increased by +10.09%
232.50 M
Increased by +217.62%
Increased by +12.70%
Increased by +188.51%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY